These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 37182875)

  • 1. Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
    Yang F; Yang L; Fang X; Deng Y; Mao R; Yan A; Wei W
    J Alzheimers Dis; 2023; 93(4):1341-1354. PubMed ID: 37182875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
    J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K; Ko PW; Jin M; Suk K; Lee HW
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
    Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
    J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis.
    Thavarajasingam SG; El-Khatib M; Vemulapalli KV; Iradukunda HAS; Laleye J; Russo S; Eichhorn C; Eide PK
    Acta Neurochir (Wien); 2022 Jul; 164(7):1719-1746. PubMed ID: 35230552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease.
    Manniche C; Simonsen AH; Hasselbalch SG; Andreasson U; Zetterberg H; Blennow K; Høgh P; Juhler M; Hejl AM
    J Alzheimers Dis; 2020; 75(3):937-947. PubMed ID: 32390628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
    Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
    Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case-control study.
    Kanemoto H; Mori E; Tanaka T; Suehiro T; Yoshiyama K; Suzuki Y; Kakeda K; Wada T; Hosomi K; Kishima H; Kazui H; Hashimoto M; Ikeda M
    Int Psychogeriatr; 2023 Sep; 35(9):509-517. PubMed ID: 34399871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
    Jingami N; Uemura K; Asada-Utsugi M; Kuzuya A; Yamada S; Ishikawa M; Kawahara T; Iwasaki T; Atsuchi M; Takahashi R; Kinoshita A
    J Alzheimers Dis; 2019; 72(1):271-277. PubMed ID: 31561378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.
    Said HM; Kaya D; Yavuz I; Dost FS; Altun ZS; Isik AT
    Clin Interv Aging; 2022; 17():467-477. PubMed ID: 35431542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus.
    Braun M; Bjurnemark C; Seo W; Freyhult E; Nyholm D; Niemelä V; Blennow K; Zetterberg H; Fällmar D; Kultima K; Virhammar J
    Fluids Barriers CNS; 2022 Feb; 19(1):15. PubMed ID: 35164790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
    Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
    J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
    Craven CL; Baudracco I; Zetterberg H; Lunn MPT; Chapman MD; Lakdawala N; Watkins LD; Toma AK
    Acta Neurochir (Wien); 2017 Dec; 159(12):2293-2300. PubMed ID: 28889317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease.
    Nordengen K; Kirsebom BE; Richter G; Pålhaugen L; Gísladóttir B; Siafarikas N; Nakling A; Rongve A; Bråthen G; Grøntvedt GR; Gonzalez F; Waterloo K; Sharma K; Karikari T; Vromen EM; Tijms BM; Visser PJ; Selnes P; Kramberger MG; Winblad B; Blennow K; Fladby T
    J Neuroinflammation; 2023 Dec; 20(1):298. PubMed ID: 38093257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
    Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH
    J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease.
    Morenas-Rodríguez E; Alcolea D; Suárez-Calvet M; Muñoz-Llahuna L; Vilaplana E; Sala I; Subirana A; Querol-Vilaseca M; Carmona-Iragui M; Illán-Gala I; Ribosa-Nogué R; Blesa R; Haass C; Fortea J; Lleó A
    Sci Rep; 2019 May; 9(1):7803. PubMed ID: 31127154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
    Kazui H; Kanemoto H; Yoshiyama K; Kishima H; Suzuki Y; Sato S; Suehiro T; Azuma S; Yoshimine T; Tanaka T
    J Neurol Sci; 2016 Oct; 369():236-241. PubMed ID: 27653897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-Tau as prognostic marker in long term follow up for patients with shunted iNPH.
    Migliorati K; Panciani PP; Pertichetti M; Borroni B; Archetti S; Rozzini L; Padovani A; Terzi L; Bruscella S; Fontanella MM
    Neurol Res; 2021 Jan; 43(1):78-85. PubMed ID: 33059546
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
    Pyykkö OT; Lumela M; Rummukainen J; Nerg O; Seppälä TT; Herukka SK; Koivisto AM; Alafuzoff I; Puli L; Savolainen S; Soininen H; Jääskeläinen JE; Hiltunen M; Zetterberg H; Leinonen V
    PLoS One; 2014; 9(3):e91974. PubMed ID: 24638077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.